United States Biotechnology & Medical Research

CASI Pharmaceuticals Inc (CASI)

Track

Ticker: CASI Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for CASI Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Proposed sale 5 Mar 2024
Value US$636,409.41 | Price 93.76 | Shares 86,509
Proposed sale 5 Mar 2024
Value US$1,133,580.55 | Price 271.61 | Shares 12,276
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-05 2024-03-05 PrS Proposed sale
2.1
Panacea Innovation Ltd

Owner
86,509
93.76
US$636,409 		86,509 93.76 US$636,409
2024-03-05 2024-03-05 PrS Proposed sale
2.1
Panacea Innovation Ltd

Owner
12,276
271.61
US$1,133,581 		12,276 271.61 US$1,133,581
2022-09-08 2022-09-08 B Purchase
2.4
Huang James
Non-Executive Director
1,286 -24.2%
222.71
US$1,609,029 		1,286 -24.2% 222.71 US$1,609,029
2022-09-08 2022-09-07 B Purchase
2.4
Huang James
Non-Executive Director
3,111 +0.9%
4.00
US$12,433 		3,111 +0.9% 4.00 US$12,433
2022-09-08 2022-09-06 B Purchase
2.4
Huang James
Non-Executive Director
19,162 +6.1%
3.89
US$74,601 		19,162 +6.1% 3.89 US$74,601
2022-09-02 2022-09-02 B Purchase
2.4
Huang James
Non-Executive Director
400 +0.1%
3.74
US$1,497 		400 +0.1% 3.74 US$1,497
2022-09-02 2022-09-01 B Purchase
2.4
Huang James
Non-Executive Director
11,821 +3.9%
3.72
US$44,008 		11,821 +3.9% 3.72 US$44,008
2022-09-02 2022-08-31 B Purchase
2.4
Huang James
Non-Executive Director
24,975 +9.0%
3.75
US$93,531 		24,975 +9.0% 3.75 US$93,531
2022-08-26 2022-08-26 B Purchase
2.4
Huang James
Non-Executive Director
39,527 +16.5%
3.75
US$148,179 		39,527 +16.5% 3.75 US$148,179
2022-08-26 2022-08-24 B Purchase
2.4
Huang James
Non-Executive Director
5,000 +2.1%
3.75
US$18,751 		5,000 +2.1% 3.75 US$18,751
2022-08-23 2022-08-23 B Purchase
2.4
Huang James
Non-Executive Director
40,000 +20.6%
3.50
US$139,992 		40,000 +20.6% 3.50 US$139,992
2022-08-23 2022-08-22 B Purchase
2.4
Huang James
Non-Executive Director
23,105 +13.5%
3.46
US$80,038 		23,105 +13.5% 3.46 US$80,038
2022-08-23 2022-08-19 B Purchase
2.4
Huang James
Non-Executive Director
171,116 +inf%
3.27
US$559,447 		171,116 +inf% 3.27 US$559,447
2022-06-17 2022-06-15 B Purchase
2.6
He Wei-Wu

Chairman and CEO

Executive Director Large shareholder
50,000 +8.4%
3.18
US$159,000 		50,000 +8.4% 3.18 US$159,000
2022-06-17 2022-06-14 B Purchase
2.6
He Wei-Wu

Chairman and CEO

Executive Director Large shareholder
2,096 +0.4%
3.06
US$6,414 		2,096 +0.4% 3.06 US$6,414
2022-06-17 2022-06-13 B Purchase
2.6
He Wei-Wu

Chairman and CEO

Executive Director Large shareholder
36,058 +6.5%
2.97
US$107,092 		36,058 +6.5% 2.97 US$107,092
2021-11-19 2021-11-18 B Purchase
2.6
He Wei-Wu

Chairman and CEO

Executive Director
200,000 +3.7%
0.98
US$196,000 		200,000 +3.7% 0.98 US$196,000
2021-11-19 2021-11-17 B Purchase
2.6
He Wei-Wu

Chairman and CEO

Executive Director
200,000 +3.9%
0.99
US$198,000 		200,000 +3.9% 0.99 US$198,000
2021-03-30 2021-03-26 B Purchase
2.6
He Wei-Wu

Chairman and CEO

Executive Director
3,000,000 +inf%
2.05
US$6,150,000 		3,000,000 +inf% 2.05 US$6,150,000
2020-12-18 2020-12-17 B Purchase
1.9
Xu Weihao

Chief Financial Officer

Officer
2,279 +29.5%
2.63
US$5,994 		2,279 +29.5% 2.63 US$5,994
2020-12-18 2020-12-17 B Purchase
1.9
Xu Weihao

Chief Financial Officer

Officer
1,721 +28.7%
2.64
US$4,543 		1,721 +28.7% 2.64 US$4,543
2020-12-18 2020-12-16 B Purchase
1.9
Xu Weihao

Chief Financial Officer

Officer
2,000 +50.0%
2.44
US$4,880 		2,000 +50.0% 2.44 US$4,880
2020-11-24 2020-11-23 B Purchase
2.6
He Wei-Wu

Chairman and CEO

Executive Director
100,000 +2.0%
2.18
US$218,000 		100,000 +2.0% 2.18 US$218,000
2020-11-24 2020-11-20 B Purchase
2.6
He Wei-Wu

Chairman and CEO

Executive Director
127,471 +2.6%
2.12
US$270,239 		127,471 +2.6% 2.12 US$270,239
2020-07-24 2020-07-22 B Purchase
2.6
He Wei-Wu

Chairman and CEO

Executive Director Large shareholder
1,200,000 +19.0%
1.90
US$2,280,000 		1,200,000 +19.0% 1.90 US$2,280,000
2020-07-24 2020-07-22 B Purchase
1.5
Zhang Larry

President

Officer
20,153 +inf%
1.90
US$38,291 		20,153 +inf% 1.90 US$38,291
2020-07-24 2020-07-22 B Purchase
2.6
He Wei-Wu

Chairman and CEO

Executive Director Large shareholder
2,952,426 +156.7%
1.90
US$5,609,609 		2,952,426 +156.7% 1.90 US$5,609,609
2020-05-21 2020-05-20 B Purchase
2.6
He Wei-Wu

Chairman and CEO

Executive Director Large shareholder
56,464 +3.1%
2.37
US$133,820 		56,464 +3.1% 2.37 US$133,820
2020-05-21 2020-05-19 B Purchase
2.6
He Wei-Wu

Chairman and CEO

Executive Director Large shareholder
29,801 +1.7%
2.03
US$60,496 		29,801 +1.7% 2.03 US$60,496
2020-05-19 2020-05-18 B Purchase
2.6
He Wei-Wu

Chairman and CEO

Executive Director Large shareholder
338,932 +23.2%
2.02
US$684,643 		338,932 +23.2% 2.02 US$684,643
2020-05-19 2020-05-15 B Purchase
2.6
He Wei-Wu

Chairman and CEO

Executive Director Large shareholder
100,000 +7.4%
1.82
US$182,000 		100,000 +7.4% 1.82 US$182,000
2020-03-30 2020-03-27 B Purchase
2.6
He Wei-Wu

Chairman and CEO

Executive Director
6,880 +0.5%
2.08
US$14,310 		6,880 +0.5% 2.08 US$14,310
2020-03-27 2020-03-26 B Purchase
2.6
He Wei-Wu

Chairman and CEO

Executive Director Large shareholder
328,095 +32.0%
2.09
US$685,719 		328,095 +32.0% 2.09 US$685,719
2020-03-27 2020-03-25 B Purchase
2.6
He Wei-Wu

Chairman and CEO

Executive Director Large shareholder
196,398 +23.7%
1.94
US$381,012 		196,398 +23.7% 1.94 US$381,012
2020-03-19 2020-03-19 B Purchase
2.6
He Wei-Wu

Chairman and CEO

Executive Director Large shareholder
234,488 +3.8%
1.57
US$368,146 		234,488 +3.8% 1.57 US$368,146
2020-03-19 2020-03-18 B Purchase
2.6
He Wei-Wu

Chairman and CEO

Executive Director Large shareholder
501,322 +9.0%
1.52
US$762,009 		501,322 +9.0% 1.52 US$762,009
2020-03-19 2020-03-17 B Purchase
2.6
He Wei-Wu

Chairman and CEO

Executive Director Large shareholder
264,192 +5.0%
1.50
US$396,288 		264,192 +5.0% 1.50 US$396,288
2019-08-20 2019-08-16 B Purchase He Wei-Wu

Chief Executive Officer

Executive Director Large shareholder
20,000 +2.5%
3.20
US$64,000 		20,000 +2.5% 3.20 US$64,000
2019-08-15 2019-08-14 B Purchase He Wei-Wu

Chief Executive Officer

Executive Director Large shareholder
160,000 +24.7%
3.17
US$507,200 		160,000 +24.7% 3.17 US$507,200
2018-03-23 2018-03-21 B Purchase IDG-Accel China Growth Fund III L.P. Large shareholder
204,320 +46.2%
3.19
US$651,781 		204,320 +46.2% 3.19 US$651,781
2018-03-23 2018-03-21 B Purchase IDG-Accel China Growth Fund III L.P. Large shareholder
2,882,098 +46.2%
3.19
US$9,193,893 		2,882,098 +46.2% 3.19 US$9,193,893
2018-03-21 2018-03-19 B Purchase He Wei-Wu Large shareholder
3,086,419 +164.9%
3.24
US$9,999,998 		3,086,419 +164.9% 3.24 US$9,999,998
2017-12-22 2017-12-22 B Purchase SPECTRUM PHARMACEUTICALS INC Large shareholder
611,740 +15.1%
0.01
US$6,117 		611,740 +15.1% 0.01 US$6,117
2017-12-22 2017-12-22 B Purchase SPECTRUM PHARMACEUTICALS INC Large shareholder
907,356 +15.1%
0.01
US$9,074 		907,356 +15.1% 0.01 US$9,074
2017-10-11 2017-10-10 B Purchase He Wei-Wu
100,000 +13.4%
1.95
US$195,000 		100,000 +13.4% 1.95 US$195,000
2017-10-10 2017-10-06 B Purchase He Wei-Wu Non-Executive Director
100,000 +15.4%
1.86
US$186,000 		100,000 +15.4% 1.86 US$186,000
2017-10-10 2017-10-05 B Purchase He Wei-Wu Non-Executive Director
100,000 +18.3%
1.80
US$180,000 		100,000 +18.3% 1.80 US$180,000
2017-09-20 2017-09-19 B Purchase He Wei-Wu
34,002 +6.6%
1.78
US$60,524 		34,002 +6.6% 1.78 US$60,524
2017-09-20 2017-09-18 B Purchase He Wei-Wu
173,500 +51.0%
1.75
US$303,625 		173,500 +51.0% 1.75 US$303,625
2017-09-18 2017-09-15 B Purchase He Wei-Wu
127,702 +60.1%
1.49
US$190,276 		127,702 +60.1% 1.49 US$190,276
2017-09-18 2017-09-14 B Purchase He Wei-Wu
187,625 +759.7%
1.22
US$228,902 		187,625 +759.7% 1.22 US$228,902
2016-11-01 2016-10-28 B Purchase SPECTRUM PHARMACEUTICALS INC Large shareholder
198,765 +5.2%
0.01
US$1,988 		198,765 +5.2% 0.01 US$1,988
2016-11-01 2016-10-28 B Purchase SPECTRUM PHARMACEUTICALS INC Large shareholder
521,692 +15.7%
0.01
US$5,217 		521,692 +15.7% 0.01 US$5,217
2016-11-01 2016-10-28 B Purchase SPECTRUM PHARMACEUTICALS INC Large shareholder
294,815 +5.2%
0.01
US$2,948 		294,815 +5.2% 0.01 US$2,948
2016-11-01 2016-10-28 B Purchase SPECTRUM PHARMACEUTICALS INC Large shareholder
773,790 +15.7%
0.01
US$7,738 		773,790 +15.7% 0.01 US$7,738
2016-10-05 2016-10-03 B Purchase He Wei-Wu Non-Executive Director
1,871,605 +inf%
1.19
US$2,227,210 		1,871,605 +inf% 1.19 US$2,227,210
2016-08-16 2016-07-20 B Purchase SPECTRUM PHARMACEUTICALS INC Large shareholder
66,255 +2.0%
0.01
US$663 		66,255 +2.0% 0.01 US$663
2016-08-16 2016-07-20 B Purchase SPECTRUM PHARMACEUTICALS INC Large shareholder
98,271 +2.0%
0.01
US$983 		98,271 +2.0% 0.01 US$983
2016-08-16 2016-07-14 B Purchase SPECTRUM PHARMACEUTICALS INC Large shareholder
394,942 +13.8%
0.01
US$3,949 		394,942 +13.8% 0.01 US$3,949
2016-08-16 2016-07-14 B Purchase SPECTRUM PHARMACEUTICALS INC Large shareholder
585,790 +13.8%
0.01
US$5,858 		585,790 +13.8% 0.01 US$5,858
2016-06-29 2016-06-24 B Purchase SPARKLE BYTE LTD Large shareholder
3,753,855 +79.1%
1.19
US$4,467,087 		3,753,855 +79.1% 1.19 US$4,467,087
2016-03-11 2016-02-22 B Purchase SPECTRUM PHARMACEUTICALS INC Large shareholder
680,113 +31.2%
0.01
US$6,801 		680,113 +31.2% 0.01 US$6,801
2016-03-11 2016-02-22 B Purchase SPECTRUM PHARMACEUTICALS INC Large shareholder
1,008,764 +31.2%
0.01
US$10,088 		1,008,764 +31.2% 0.01 US$10,088
2016-01-21 2016-01-19 B Purchase Ren Ken

CEO and Director

Executive Director
300 +2.0%
0.71
US$213 		300 +2.0% 0.71 US$213
2016-01-21 2016-01-19 B Purchase Ren Ken

CEO and Director

Executive Director
6,063 +70.2%
0.72
US$4,365 		6,063 +70.2% 0.72 US$4,365
2016-01-21 2016-01-19 B Purchase Ren Ken

CEO and Director

Executive Director
1,100 +14.6%
0.74
US$814 		1,100 +14.6% 0.74 US$814
2016-01-21 2016-01-19 B Purchase Hu Cynthia W.

COO

Officer
11,837 +199.0%
0.72
US$8,519 		11,837 +199.0% 0.72 US$8,519
2016-01-21 2016-01-19 B Purchase Hu Cynthia W.

COO

Officer
4,163 +233.2%
0.72
US$2,993 		4,163 +233.2% 0.72 US$2,993
2016-01-21 2016-01-19 B Purchase Hu Cynthia W.

COO

Officer
400 +28.9%
0.75
US$300 		400 +28.9% 0.75 US$300
2016-01-21 2016-01-19 B Purchase Ren Ken Keyong

CEO and Director

Executive Director
300 +2.0%
0.71
US$213 		300 +2.0% 0.71 US$213
2016-01-21 2016-01-19 B Purchase Ren Ken Keyong

CEO and Director

Executive Director
6,063 +70.2%
0.72
US$4,365 		6,063 +70.2% 0.72 US$4,365
2016-01-21 2016-01-19 B Purchase Ren Ken Keyong

CEO and Director

Executive Director
1,100 +14.6%
0.74
US$814 		1,100 +14.6% 0.74 US$814
2016-01-21 2016-01-19 B Purchase Ren Ken

CEO and Director

Executive Director
7,537 +inf%
0.73
US$5,502 		7,537 +inf% 0.73 US$5,502
2016-01-21 2016-01-19 B Purchase Hu Cynthia W.

COO

Officer
400 +40.6%
0.75
US$299 		400 +40.6% 0.75 US$299
2016-01-21 2016-01-19 B Purchase Ren Ken Keyong

CEO and Director

Executive Director
7,537 +inf%
0.73
US$5,502 		7,537 +inf% 0.73 US$5,502
Explore more

More insider trading research around CASI Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America